Skip to main content
Top
Published in: BMC Cancer 1/2021

Open Access 01-12-2021 | Melanoma | Research article

IRF4-activated TEX41 promotes the malignant behaviors of melanoma cells by targeting miR-103a-3p/C1QB axis

Authors: Yingna Zheng, Wu Zhou, Min Li, Ruixue Xu, Shuai Zhang, Ying Liu, Ying Cen

Published in: BMC Cancer | Issue 1/2021

Login to get access

Abstract

Background

Malignant melanoma is an aggressive skin cancer and a tumor of melanocytic origin. Recent studies have suggested that long non-coding RNAs (lncRNAs) play crucial regulatory roles in multiple malignancies, including melanoma. Testis expressed 41 (TEX41) is a relatively new lncRNA whose mechanism in melanoma remains vague.

Aims

This study aimed to explore the role and specific mechanism of TEX41 in melanoma.

Methods

The expression of genes involved in this study was determined by qRT-PCR. Functional assays were conducted to analyze the role of relevant genes in melanoma cells. The interaction between TEX41 promoter and IRF4 as well as the relationship among TEX41, miR-103a-3p and C1QB was verified by mechanism assays.

Results

IRF4 up-regulated TEX41 at the transcriptional level in melanoma cells. TEX41 knockdown hindered melanoma cell proliferation, migration and invasion while promoting cell apoptosis. TEX41 bound to miR-103a-3p and regulated C1QB. The suppressive impact of TEX41 depletion on melanoma cell malignant behaviors could be counteracted by miR-103a-3p inhibition or C1QB overexpression. Moreover, IRF4 could facilitate melanoma cell growth via up-regulating C1QB.

Conclusions

IRF4-activated TEX41 sequestered miR-103a-3p and modulated C1QB to promote melanoma cell malignant behaviors, for which TEX41 might be regarded as a potential therapeutic target for melanoma.
Appendix
Available only for authorised users
Literature
1.
go back to reference Long J, Pi X. lncRNA-MEG3 Suppresses the Proliferation and Invasion of Melanoma by Regulating CYLD Expression Mediated by Sponging miR-499-5p. BioMed Res Int. 2018;2018:2086564.CrossRef Long J, Pi X. lncRNA-MEG3 Suppresses the Proliferation and Invasion of Melanoma by Regulating CYLD Expression Mediated by Sponging miR-499-5p. BioMed Res Int. 2018;2018:2086564.CrossRef
2.
go back to reference Pavri SN, Clune J, Ariyan S, Narayan D. Malignant Melanoma: Beyond the Basics. Plastic Reconstructive Surg. 2016;138(2):330e-40e.CrossRef Pavri SN, Clune J, Ariyan S, Narayan D. Malignant Melanoma: Beyond the Basics. Plastic Reconstructive Surg. 2016;138(2):330e-40e.CrossRef
3.
go back to reference Abbas O, Miller DD, Bhawan J. Cutaneous malignant melanoma: update on diagnostic and prognostic biomarkers. Am J Dermatopathol. 2014;36(5):363–79.CrossRef Abbas O, Miller DD, Bhawan J. Cutaneous malignant melanoma: update on diagnostic and prognostic biomarkers. Am J Dermatopathol. 2014;36(5):363–79.CrossRef
4.
go back to reference Rastrelli M, Tropea S, Rossi CR, Alaibac M. Melanoma: epidemiology, risk factors, pathogenesis, diagnosis and classification. In vivo (Athens, Greece). 2014;28(6):1005–11. Rastrelli M, Tropea S, Rossi CR, Alaibac M. Melanoma: epidemiology, risk factors, pathogenesis, diagnosis and classification. In vivo (Athens, Greece). 2014;28(6):1005–11.
5.
go back to reference Yang G, Lu X, Yuan L. LncRNA: a link between RNA and cancer. Biochimica et Biophysica Acta. 2014;1839(11):1097–109.CrossRef Yang G, Lu X, Yuan L. LncRNA: a link between RNA and cancer. Biochimica et Biophysica Acta. 2014;1839(11):1097–109.CrossRef
7.
go back to reference Peng WX, Koirala P, Mo YY. LncRNA-mediated regulation of cell signaling in cancer. Oncogene. 2017;36(41):5661–7.CrossRef Peng WX, Koirala P, Mo YY. LncRNA-mediated regulation of cell signaling in cancer. Oncogene. 2017;36(41):5661–7.CrossRef
8.
go back to reference Chen T, Yang Z, Liu C, Wang L, Yang J, Chen L, et al. Circ_0078767 suppresses non-small-cell lung cancer by protecting RASSF1A expression via sponging miR-330-3p. Cell Proliferation. 2019;52(2):e12548.CrossRef Chen T, Yang Z, Liu C, Wang L, Yang J, Chen L, et al. Circ_0078767 suppresses non-small-cell lung cancer by protecting RASSF1A expression via sponging miR-330-3p. Cell Proliferation. 2019;52(2):e12548.CrossRef
9.
go back to reference Xiao W, Yin A. LINC0638 lncRNA is involved in the local recurrence of melanoma following surgical resection. Oncol Letters. 2019;18(1):101–8.PubMedPubMedCentral Xiao W, Yin A. LINC0638 lncRNA is involved in the local recurrence of melanoma following surgical resection. Oncol Letters. 2019;18(1):101–8.PubMedPubMedCentral
10.
go back to reference Coe EA, Tan JY, Shapiro M, Louphrasitthiphol P, Bassett AR, Marques AC, et al. The MITF-SOX10 regulated long non-coding RNA DIRC3 is a melanoma tumour suppressor. PLoS Genet. 2019;15(12):e1008501.CrossRef Coe EA, Tan JY, Shapiro M, Louphrasitthiphol P, Bassett AR, Marques AC, et al. The MITF-SOX10 regulated long non-coding RNA DIRC3 is a melanoma tumour suppressor. PLoS Genet. 2019;15(12):e1008501.CrossRef
11.
go back to reference Li W, Qi Y, Cui X, Huo Q, Zhu L, Zhang A, et al. Characteristic of HPV Integration in the Genome and Transcriptome of Cervical Cancer Tissues. BioMed Res Int. 2018;2018:6242173.PubMedPubMedCentral Li W, Qi Y, Cui X, Huo Q, Zhu L, Zhang A, et al. Characteristic of HPV Integration in the Genome and Transcriptome of Cervical Cancer Tissues. BioMed Res Int. 2018;2018:6242173.PubMedPubMedCentral
12.
go back to reference Yang M, Huang W, Sun Y, Liang H, Chen M, Wu X, et al. Prognosis and modulation mechanisms of COMMD6 in human tumours based on expression profiling and comprehensive bioinformatics analysis. Brit J Cancer. 2019;121(8):699–709.CrossRef Yang M, Huang W, Sun Y, Liang H, Chen M, Wu X, et al. Prognosis and modulation mechanisms of COMMD6 in human tumours based on expression profiling and comprehensive bioinformatics analysis. Brit J Cancer. 2019;121(8):699–709.CrossRef
13.
go back to reference Ozemri Sag S, Yakut T, Gorukmez O, Gorukmez O, Ture M, Karkucak M, et al. Qualitative and quantitative evaluation of the BCR-ABL fusion gene in chronic myelogenous leukemia by flourescence in situ hybridization and molecular genetic methods. Genet Test Mol Biomarkers. 2015;19(10):584–8.CrossRef Ozemri Sag S, Yakut T, Gorukmez O, Gorukmez O, Ture M, Karkucak M, et al. Qualitative and quantitative evaluation of the BCR-ABL fusion gene in chronic myelogenous leukemia by flourescence in situ hybridization and molecular genetic methods. Genet Test Mol Biomarkers. 2015;19(10):584–8.CrossRef
14.
go back to reference Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45(W1):W98-w102.CrossRef Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45(W1):W98-w102.CrossRef
15.
go back to reference Wang Z, Jensen MA, Zenklusen JC. A Practical Guide to The Cancer Genome Atlas (TCGA). Methods Molecular Biol. 2016;1418:111–41.CrossRef Wang Z, Jensen MA, Zenklusen JC. A Practical Guide to The Cancer Genome Atlas (TCGA). Methods Molecular Biol. 2016;1418:111–41.CrossRef
16.
go back to reference Chen HF, Wang JK. [The databases of transcription factors.]. Yi chuan = Hereditas. 2010;32(10):1009–17.CrossRef Chen HF, Wang JK. [The databases of transcription factors.]. Yi chuan = Hereditas. 2010;32(10):1009–17.CrossRef
17.
go back to reference Yang JH, Li JH, Shao P, Zhou H, Chen YQ, Qu LH. starBase: a database for exploring microRNA-mRNA interaction maps from Argonaute CLIP-Seq and Degradome-Seq data. Nucleic Acids Res. 2011;39(Database issue):D202-9.PubMed Yang JH, Li JH, Shao P, Zhou H, Chen YQ, Qu LH. starBase: a database for exploring microRNA-mRNA interaction maps from Argonaute CLIP-Seq and Degradome-Seq data. Nucleic Acids Res. 2011;39(Database issue):D202-9.PubMed
18.
go back to reference Li R, Jiang S, Li W, Hong H, Zhao C, Huang X, et al. Exploration of prognosis-related microRNA and transcription factor co-regulatory networks across cancer types. RNA Biol. 2019;16(8):1010–21.CrossRef Li R, Jiang S, Li W, Hong H, Zhao C, Huang X, et al. Exploration of prognosis-related microRNA and transcription factor co-regulatory networks across cancer types. RNA Biol. 2019;16(8):1010–21.CrossRef
19.
go back to reference Thomson DW, Dinger ME. Endogenous microRNA sponges: evidence and controversy. Nature Reviews Genet. 2016;17(5):272–83.CrossRef Thomson DW, Dinger ME. Endogenous microRNA sponges: evidence and controversy. Nature Reviews Genet. 2016;17(5):272–83.CrossRef
20.
go back to reference Zhou RS, Zhang EX, Sun QF, Ye ZJ, Liu JW, Zhou DH, et al. Integrated analysis of lncRNA-miRNA-mRNA ceRNA network in squamous cell carcinoma of tongue. BMC Cancer. 2019;19(1):779.CrossRef Zhou RS, Zhang EX, Sun QF, Ye ZJ, Liu JW, Zhou DH, et al. Integrated analysis of lncRNA-miRNA-mRNA ceRNA network in squamous cell carcinoma of tongue. BMC Cancer. 2019;19(1):779.CrossRef
21.
go back to reference Lerner BA, Stewart LA, Horowitz DP, Carvajal RD. Mucosal Melanoma: New Insights and Therapeutic Options for a Unique and Aggressive Disease. Oncology (Williston Park, NY). 2017;31(11):e23-e32. Lerner BA, Stewart LA, Horowitz DP, Carvajal RD. Mucosal Melanoma: New Insights and Therapeutic Options for a Unique and Aggressive Disease. Oncology (Williston Park, NY). 2017;31(11):e23-e32.
22.
go back to reference Yu X, Zheng H, Tse G, Chan MT, Wu WK. Long non-coding RNAs in melanoma. Cell Proliferation. 2018;51(4):e12457.CrossRef Yu X, Zheng H, Tse G, Chan MT, Wu WK. Long non-coding RNAs in melanoma. Cell Proliferation. 2018;51(4):e12457.CrossRef
23.
go back to reference Sun Z, Wu F, Yang Y, Liu F, Mo F, Chen J, et al. MiR-144-3p Inhibits BMSC Proliferation and Osteogenic Differentiation Via Targeting FZD4 in Steroid-Associated Osteonecrosis. Curr Pharmaceutical Design. 2019;25(45):4806–12.CrossRef Sun Z, Wu F, Yang Y, Liu F, Mo F, Chen J, et al. MiR-144-3p Inhibits BMSC Proliferation and Osteogenic Differentiation Via Targeting FZD4 in Steroid-Associated Osteonecrosis. Curr Pharmaceutical Design. 2019;25(45):4806–12.CrossRef
24.
go back to reference Sarkar D, Leung EY, Baguley BC, Finlay GJ, Askarian-Amiri ME. Epigenetic regulation in human melanoma: past and future. Epigenetics. 2015;10(2):103–21.CrossRef Sarkar D, Leung EY, Baguley BC, Finlay GJ, Askarian-Amiri ME. Epigenetic regulation in human melanoma: past and future. Epigenetics. 2015;10(2):103–21.CrossRef
25.
go back to reference Qi X, Zhang DH, Wu N, Xiao JH, Wang X, Ma W. ceRNA in cancer: possible functions and clinical implications. J Med Genet. 2015;52(10):710–8.CrossRef Qi X, Zhang DH, Wu N, Xiao JH, Wang X, Ma W. ceRNA in cancer: possible functions and clinical implications. J Med Genet. 2015;52(10):710–8.CrossRef
26.
go back to reference Jiang J, Ding Y, Wu M, Lyu X, Wang H, Chen Y, et al. Identification of TYROBP and C1QB as Two Novel Key Genes With Prognostic Value in Gastric Cancer by Network Analysis. Front Oncol. 2020;10:1765.CrossRef Jiang J, Ding Y, Wu M, Lyu X, Wang H, Chen Y, et al. Identification of TYROBP and C1QB as Two Novel Key Genes With Prognostic Value in Gastric Cancer by Network Analysis. Front Oncol. 2020;10:1765.CrossRef
27.
go back to reference Niesen CE, Xu J, Fan X, Li X, Wheeler CJ, Mamelak AN, et al. Transcriptomic profiling of human peritumoral neocortex tissues revealed genes possibly involved in tumor-induced epilepsy. PloS one. 2013;8(2):e56077.CrossRef Niesen CE, Xu J, Fan X, Li X, Wheeler CJ, Mamelak AN, et al. Transcriptomic profiling of human peritumoral neocortex tissues revealed genes possibly involved in tumor-induced epilepsy. PloS one. 2013;8(2):e56077.CrossRef
28.
go back to reference Yamada Y, Arai T, Kojima S, Sugawara S, Kato M, Okato A, et al. Regulation of antitumor miR-144-5p targets oncogenes: Direct regulation of syndecan-3 and its clinical significance. Cancer Sci. 2018;109(9):2919–36.CrossRef Yamada Y, Arai T, Kojima S, Sugawara S, Kato M, Okato A, et al. Regulation of antitumor miR-144-5p targets oncogenes: Direct regulation of syndecan-3 and its clinical significance. Cancer Sci. 2018;109(9):2919–36.CrossRef
29.
go back to reference Luo Y, Robinson S, Fujita J, Siconolfi L, Magidson J, Edwards CK, et al. Transcriptome profiling of whole blood cells identifies PLEK2 and C1QB in human melanoma. PloS one. 2011;6(6):e20971.CrossRef Luo Y, Robinson S, Fujita J, Siconolfi L, Magidson J, Edwards CK, et al. Transcriptome profiling of whole blood cells identifies PLEK2 and C1QB in human melanoma. PloS one. 2011;6(6):e20971.CrossRef
Metadata
Title
IRF4-activated TEX41 promotes the malignant behaviors of melanoma cells by targeting miR-103a-3p/C1QB axis
Authors
Yingna Zheng
Wu Zhou
Min Li
Ruixue Xu
Shuai Zhang
Ying Liu
Ying Cen
Publication date
01-12-2021
Publisher
BioMed Central
Keywords
Melanoma
Melanoma
Published in
BMC Cancer / Issue 1/2021
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-021-09039-1

Other articles of this Issue 1/2021

BMC Cancer 1/2021 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine